MALESCI, Alberto Carlo Piero
 Distribuzione geografica
Continente #
NA - Nord America 10.858
AS - Asia 5.751
EU - Europa 1.839
SA - Sud America 998
AF - Africa 315
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 16
Totale 19.809
Nazione #
US - Stati Uniti d'America 10.641
SG - Singapore 3.665
CN - Cina 890
BR - Brasile 839
VN - Vietnam 478
FI - Finlandia 388
IE - Irlanda 251
NG - Nigeria 215
IT - Italia 206
DE - Germania 202
HK - Hong Kong 166
FR - Francia 160
CA - Canada 144
GB - Regno Unito 131
NL - Olanda 105
SE - Svezia 97
TR - Turchia 97
IN - India 96
AR - Argentina 57
MX - Messico 54
IQ - Iraq 50
BD - Bangladesh 49
BE - Belgio 41
RU - Federazione Russa 40
JP - Giappone 34
ES - Italia 33
PL - Polonia 33
A2 - ???statistics.table.value.countryCode.A2??? 30
UA - Ucraina 30
IL - Israele 29
CL - Cile 28
ZA - Sudafrica 25
ID - Indonesia 20
MK - Macedonia 20
VE - Venezuela 20
PH - Filippine 19
PK - Pakistan 19
CZ - Repubblica Ceca 18
RO - Romania 18
SA - Arabia Saudita 17
EC - Ecuador 16
AU - Australia 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
CO - Colombia 12
DZ - Algeria 12
KE - Kenya 12
IR - Iran 11
KR - Corea 11
NP - Nepal 11
TN - Tunisia 11
GR - Grecia 9
KG - Kirghizistan 9
KZ - Kazakistan 9
NO - Norvegia 9
AZ - Azerbaigian 8
EG - Egitto 8
PE - Perù 8
UY - Uruguay 8
UZ - Uzbekistan 8
AL - Albania 7
CH - Svizzera 7
JO - Giordania 7
LT - Lituania 6
OM - Oman 6
PS - Palestinian Territory 6
PY - Paraguay 6
AO - Angola 5
AT - Austria 5
MD - Moldavia 5
BO - Bolivia 4
HU - Ungheria 4
MY - Malesia 4
BN - Brunei Darussalam 3
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 19.794
Città #
Singapore 1.849
Wilmington 1.548
Chandler 1.490
Dallas 823
San Mateo 577
The Dalles 577
Ann Arbor 505
Ashburn 504
Shanghai 419
Helsinki 380
Boardman 317
Leawood 275
San Jose 252
Dublin 248
New York 241
Lawrence 238
Princeton 238
Benin City 214
Beijing 204
Ho Chi Minh City 163
Hong Kong 158
Fairfield 141
Paris 138
Woodbridge 132
Columbus 120
Hanoi 119
Toronto 96
Amsterdam 93
São Paulo 76
Milan 68
Kocaeli 65
Seattle 63
London 60
Los Angeles 59
Council Bluffs 58
Falls Church 51
Phoenix 46
Brussels 38
Norwalk 38
Santa Clara 38
San Diego 37
Munich 32
Rio de Janeiro 31
Tokyo 27
Orem 26
Falkenstein 25
Abbiategrasso 23
Baghdad 22
Houston 22
Monmouth Junction 22
Belo Horizonte 21
Clearwater 21
Brooklyn 20
Haiphong 19
Warsaw 19
Da Nang 18
Mexico City 18
Pune 18
Curitiba 16
Frankfurt am Main 16
Chennai 15
Brasília 14
Chicago 13
Naples 13
Tappahannock 13
Brno 12
Campinas 12
Dhaka 12
Jakarta 12
Montreal 12
San Francisco 12
Johannesburg 11
Mumbai 11
Redwood City 11
Des Moines 10
Manchester 10
Seoul 10
Bishkek 9
Boston 9
Monterrey 9
Nairobi 9
Skopje 9
Atlanta 8
Baku 8
Buffalo 8
Moscow 8
Sacramento 8
Santiago 8
Stockholm 8
Turku 8
Andover 7
Betim 7
Buenos Aires 7
Lahore 7
Maracaibo 7
Montevideo 7
Ottawa 7
Porto Alegre 7
Redmond 7
São Gonçalo 7
Totale 13.554
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 306
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Endoscopic submucosal dissection of early gastric neoplastic lesions : a western series 171
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia 153
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 149
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 148
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 145
Quantitative evaluation of RASSFIA methylation in the non-lesional, regenerative and neoplastic liver 141
Balanced poropofol sedation in patients undergoing EUS-FNA: a pilot study to assess feasibility and safety 138
Adalimumab in ulcerative colitis: hypes and hopes 134
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 132
Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases 132
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 125
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 125
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 124
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 124
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 122
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 119
Autonomic nervous system dysregulation in irritable bowel syndrome 119
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 118
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 118
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 117
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 116
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 113
Hereditary or sporadic polyposis syndromes 112
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer 112
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 112
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine 111
Achalasia with dense eosinophilic infiltrate responds to steroidal therapy 110
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 110
Colitis-associated cancer: the dark side of inflammatory bowel disease 110
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 109
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 109
Fractionation of immunoreactive cholecystokinin by adsorption to QUSO or talc 108
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 108
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 107
Imaging Modalities for Perianal Crohn's Disease 106
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 106
A new metal stent with a controlled-release system for palliation of malignant dysphagia a prospective, multicenter study 106
Costo sociale annuo della dispepsia funzionale dopo l'eradicazione dell'Helicobacter pylori : risultati di un'indagine in centri di endoscopia digestiva 106
Circadian acidity pattern in gastric ulcers at different sites 106
C(Tr)/C(Cr) ratio in pancreatic disease 105
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 105
K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers 104
Prognostic value of innate and adaptive immunity in colorectal cancer 103
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 102
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 102
Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study 101
Abdominal cocoon or idiopathic encapsulating peritoneal sclerosis : magnetic resonance imaging 101
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 100
A case of esophageal squamous cell intraepithelial neoplasia with positivity for type 16 human papillomavirus successfully treated with radiofrequency ablation 99
Observation of thoracic duct morphology in portal hypertension by endoscopic ultrasound 98
SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia 98
Presence of twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors 98
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 97
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 96
Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma : results from a prospective Western series 96
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 95
Microsatellite instability and therapeutic consequences in colorectal cancer 95
Italian consensus guidelines for chronic pancreatitis 95
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 95
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects 94
Tipizzazione linfocitaria nelle epatopatie croniche 94
High efficacy of endoscopic submucosal dissection for rectal laterally spreading tumors larger than 3 cm 94
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 94
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 94
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 93
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 93
Low density of CD3+ cells at the invasion front and increased risk of liver metastases development in microsatellite-stable colorectal cancer patients 93
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 93
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 93
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 93
Nissen fundoplication after failure of endoluminal fundoplication: short term results 92
No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis 92
Serum pepsinogen I elevation in cigarette smokers 92
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 92
Gastric histology and function tests in Italian patients with dermatitis herpetiformis 91
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 91
Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability 90
Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes 89
Cholecystokinin-converting enzymes in brain 89
Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography 89
CA 19-9 in serum and pancreatic juice : its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis 89
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 89
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 89
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 89
Tumour-associated macrophages as treatment targets in oncology 88
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers 88
Effect of Oral Administration of Methylene Blue MMx (R) Tablets on Double-Stranded DNA Damage Assessed by gamma H2AX Analysis of Colon Biopsy Samples - A Single Center, Open Label, Safety, Phase II Study 88
CA 19-9 and diagnosis of pancreatic carcinoma 87
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 87
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 87
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease 86
Pancreatic polypeptide response to food and cerulein in patients with total gastrectomy 85
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 85
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices : a prospective multicenter study 85
Short-term outcomes of laparoscopy combined with enhanced recovery pathway after ileocecal resection for Crohn's disease : a case-matched analysis 85
Modificazioni di parametri ormonali e biochimici nell'adenocarcinoma gastrico 84
Evaluation of peripheral and CNS biochemical changes in models of acute and chronic experimental hepatic insufficiency in the rat 84
Studio endoscopico sulla tollerabilità gastroduodenale di farmaci ad attiva antalgica-antireumatica-antiflogistica: il feprazone=Endoscopic assessment of the gastric tolerability of antalgic, anti-rheumatic and anti-inflammatory drugs: Feprazone 84
Totale 10.719
Categoria #
all - tutte 131.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021839 0 0 0 0 0 0 0 0 0 362 19 458
2021/20221.916 193 30 53 321 40 38 58 210 142 265 479 87
2022/20233.791 540 163 345 458 343 341 3 315 723 290 235 35
2023/20242.019 194 229 370 136 58 277 109 101 51 44 136 314
2024/20253.044 130 111 35 131 129 392 170 380 353 620 339 254
2025/20266.555 1.044 422 823 499 250 247 2.105 418 409 338 0 0
Totale 20.325